Thiazolidinediones for Diabetes: Evidence and Outcomes

Ver informe de evidencia

Evidence on outcomes studied for Thiazolidinediones

Evidence related to thiazolidinedione therapies in diabetes studies.

Crea tu Evidence Workspace

Guarda evidencia sobre los temas que te importan.

Studies

Evidence Pairs

Moderate Evidence

Evidence Strength: 63/100

Evidence Intelligence™

Evidence Summary

A structured summary of where the evidence is strongest, mixed, or still emerging.

Executive Summary

Thiazolidinediones evidence appears to center on HbA1c.

Among 9 indexed studies and 1 interventions, the strongest signals are summarized from the available evidence. HbA1c appears to be one of the clearer current evidence signals.

Evidence is consistently positive across multiple studies.
Some evidence is positive, but results are not consistent across all studies.
Early findings are encouraging, but stronger trials are needed.

Caution

This summary reflects the currently indexed evidence and should not be interpreted as treatment advice.

Key Finding

Evidence is consistently positive across multiple studies.

Interventions with strongest consistent evidence

Strongest consistent evidence

Why it matters

Consistent positive findings are easier to interpret than isolated or mixed results.

Interpretation

HbA1c appears to have a consistent beneficial signal in the indexed evidence.

View supporting studies

Evidence basis: 2 evidence pairs - 5 studies

Why this appears here

Strong evidenceConsistent resultsPositive effect signalMultiple RCTsModerate evidence

HbA1c

4 studies

EvidenceScore™

79/100

ConsistencyScore™

100/100

BMI

2 studies

EvidenceScore™

69/100

ConsistencyScore™

100/100

Evidence Snapshot

Studies

Interventions

Outcomes

Strong evidence signals

Mixed evidence areas

Key Findings

Key patterns and insights identified across the research landscape

Strong positive signal

HbA1c

Across 4 studies, Pioglitazone shows a consistent strong positive signal for HbA1c.

4 studies

EvidenceScore™: 79/100

View supporting studies

Strong positive signal

BMI

Across 2 studies, Pioglitazone shows a consistent strong positive signal for BMI.

2 studies

EvidenceScore™: 69/100

View supporting studies

Moderate positive signal

Controlled attenuation parameter

Across 2 studies, Pioglitazone shows a moderate positive signal for Controlled attenuation parameter.

2 studies

EvidenceScore™: 69/100

View supporting studies

Moderate positive signal

Liver fat content

Across 2 studies, Pioglitazone shows a moderate positive signal for Liver fat content.

2 studies

EvidenceScore™: 69/100

View supporting studies

Neutral signal

Liver stiffness measure

Across 2 studies, Pioglitazone shows a consistent neutral signal for Liver stiffness measure.

2 studies

EvidenceScore™: 69/100

View supporting studies

Supporting Evidence

Mixed or conflicting evidence

Some evidence is positive, but results are not consistent across all studies.

Areas where results are mixed

Why it matters

Mixed results suggest effects may depend on population, comparator, duration, or study design.

Interpretation

Controlled attenuation parameter is mixed in the currently indexed evidence.

Caution

Some supporting studies reported neutral, negative, or mixed findings.

Top entities

Controlled attenuation parameter

Liver fat content

Controlled attenuation parameter

2 studies

EvidenceScore™

69/100

ConsistencyScore™

50/100

Why this appears here

Mixed Or Conflicting ResultsPositive Signal PresentNeutral Results Present

Evidence basis: 2 evidence pairs - 4 studies

View supporting studies

Promising but understudied

Early findings are encouraging, but stronger trials are needed.

Promising areas needing more evidence

Why it matters

Promising signals can guide further review, but they should not be treated as settled evidence.

Interpretation

HbA1c may have a beneficial signal, but the evidence base is still developing.

Caution

Current support is limited by study volume, RCT depth, or evidence strength.

Top entities

HbA1c

BMI

HbA1c

4 studies

EvidenceScore™

79/100

ConsistencyScore™

100/100

Why this appears here

Positive effect signalLimited study volumeFew randomized trialsEmerging Or Limited Strength

Evidence basis: 5 evidence pairs - 9 studies

View supporting studies

Explore the Evidence

The sections below provide the complete evidence questions, supporting relationships, and underlying studies behind the summary above.

Preguntas respondidas por la evidencia

What outcomes has Thiazolidinediones been studied for?

outcomes studied

Emerging Evidence

HbA1c, BMI, and Liver stiffness measure are among the most studied areas in relation to Thiazolidinediones.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

1
HbA1c
EvidenceScore™ Strong | EvidenceScore™ 79.0 | strong positive | ConsistencyScore™ Consistent | 4 studies
2
BMI
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | strong positive | ConsistencyScore™ Consistent | 2 studies
3
Controlled attenuation parameter
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | moderate positive | ConsistencyScore™ Mixed | 2 studies

Why this answer: This answer is based on 9 supporting studies and existing graph evidence signals.

Limitations

Consistency cannot yet be determined.
Population details are unavailable.

Does Thiazolidinediones improve HbA1c?

intervention outcome_effect

Strong Evidence

Thiazolidinediones appears to improve HbA1c.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

1
HbA1c
EvidenceScore™ Strong | EvidenceScore™ 79.0 | strong positive | ConsistencyScore™ Consistent | 4 studies

Why this answer: This answer is based on 4 supporting studies with consistent results and a positive effect signal.

Limitations

Population details are unavailable.

Which outcomes have the strongest evidence for Thiazolidinediones?

evidence strength

Moderate Evidence

HbA1c, BMI, and Liver stiffness measure have the strongest available evidence signals for Thiazolidinediones.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

1
HbA1c
EvidenceScore™ Strong | EvidenceScore™ 79.0 | strong positive | ConsistencyScore™ Consistent | 4 studies
2
BMI
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | strong positive | ConsistencyScore™ Consistent | 2 studies
3
Controlled attenuation parameter
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | moderate positive | ConsistencyScore™ Mixed | 2 studies

Why this answer: This answer is based on 8 supporting studies with consistent results and a positive effect signal.

Limitations

Population details are unavailable.

Where does Thiazolidinediones need more research?

research gaps

Moderate Evidence

BMI, Liver stiffness measure, and Controlled attenuation parameter need more research in relation to Thiazolidinediones.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

1
BMI
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | strong positive | ConsistencyScore™ Consistent | 2 studies
2
Controlled attenuation parameter
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | moderate positive | ConsistencyScore™ Mixed | 2 studies
3
Liver fat content
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | moderate positive | ConsistencyScore™ Mixed | 2 studies

Why this answer: This answer is based on 6 supporting studies with consistent results and a positive effect signal.

Limitations

Population details are unavailable.

How does Thiazolidinediones compare across studied outcomes?

cross outcome_comparison

Moderate Evidence

HbA1c, BMI, and Liver stiffness measure have available evidence for Thiazolidinediones, but the comparison requires review of the underlying studies.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

1
HbA1c
EvidenceScore™ Strong | EvidenceScore™ 79.0 | strong positive | ConsistencyScore™ Consistent | 4 studies
2
BMI
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | strong positive | ConsistencyScore™ Consistent | 2 studies
3
Controlled attenuation parameter
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | moderate positive | ConsistencyScore™ Mixed | 2 studies

Why this answer: This answer is based on 8 supporting studies with consistent results and a positive effect signal.

Limitations

Population details are unavailable.

Evidence summary for AI and search

Among 9 indexed studies and 1 interventions, the strongest signals are summarized from the available evidence. HbA1c appears to be one of the clearer current evidence signals.